Wells Fargo’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q3 | – | Sell |
-1,519
| Closed | -$84K | – | 7613 |
|
2022
Q2 | $84K | Buy |
1,519
+319
| +27% | +$17.6K | ﹤0.01% | 4484 |
|
2022
Q1 | $38K | Hold |
1,200
| – | – | ﹤0.01% | 5448 |
|
2021
Q4 | $26K | Hold |
1,200
| – | – | ﹤0.01% | 5758 |
|
2021
Q3 | $26K | Hold |
1,200
| – | – | ﹤0.01% | 5568 |
|
2021
Q2 | $23K | Buy |
1,200
+1,000
| +500% | +$19.2K | ﹤0.01% | 5522 |
|
2021
Q1 | $3K | Hold |
200
| – | – | ﹤0.01% | 6236 |
|
2020
Q4 | $3K | Hold |
200
| – | – | ﹤0.01% | 5934 |
|
2020
Q3 | $2K | Hold |
200
| – | – | ﹤0.01% | 5812 |
|
2020
Q2 | $2K | Hold |
200
| – | – | ﹤0.01% | 5746 |
|
2020
Q1 | $2K | Sell |
200
-177
| -47% | -$1.77K | ﹤0.01% | 5699 |
|
2019
Q4 | $5K | Sell |
377
-6
| -2% | -$80 | ﹤0.01% | 5678 |
|
2019
Q3 | $6K | Buy |
383
+1
| +0.3% | +$16 | ﹤0.01% | 5621 |
|
2019
Q2 | $8K | Hold |
382
| – | – | ﹤0.01% | 5569 |
|
2019
Q1 | $27K | Hold |
382
| – | – | ﹤0.01% | 5354 |
|
2018
Q4 | $20K | Sell |
382
-291
| -43% | -$15.2K | ﹤0.01% | 5435 |
|
2018
Q3 | $45K | Sell |
673
-40
| -6% | -$2.68K | ﹤0.01% | 5325 |
|
2018
Q2 | $85K | Hold |
713
| – | – | ﹤0.01% | 5201 |
|
2018
Q1 | $59K | Buy |
713
+155
| +28% | +$12.8K | ﹤0.01% | 5238 |
|
2017
Q4 | $83K | Buy |
558
+329
| +144% | +$48.9K | ﹤0.01% | 5134 |
|
2017
Q3 | $14K | Hold |
229
| – | – | ﹤0.01% | 5456 |
|
2017
Q2 | $11K | Hold |
229
| – | – | ﹤0.01% | 5420 |
|
2017
Q1 | $14K | Hold |
229
| – | – | ﹤0.01% | 5417 |
|
2016
Q4 | $14K | Buy |
+229
| New | +$14K | ﹤0.01% | 5387 |
|